The Central-Versus Peripheral-Mediated Effects of Liraglutide Enhancement on Insulin Secretion is Dependent on the Stage of Diabetes
Chiara Saponaro(University of Pisa), Caroline Bonner(Inserm), François Pattou(Inserm), Markus Schwaninger(University of Lübeck), Rubén Nogueiras(Universidade de Santiago de Compostela), Ana Acosta-Montalvo(Inserm), Shiqian Chen(Imperial College London), Eve Wemelle(Inserm), Frank W. Pfrieger(Institut des Neurosciences Cellulaires et Intégratives), Nathalie Delalleau(Inserm), Mónica Imbernón(Universidade de Santiago de Compostela), Ben Jones(Hammersmith Hospital), Julien Thévenet(Inserm), Eleonora Deligia(Inserm), Isaline Louvet(Inserm), Claude Knauf(Université Toulouse III - Paul Sabatier), Gianni Pasquetti(Inserm), Lorea Zubiaga(Inserm), Vincent Prévot(Inserm), Julie Kerr‐Conte(Inserm), F. Auger(Direction des Energies), Maria Moreno Lopez(Inserm), Bart Staels(Inserm), Markus Muehlemann(Université de Lille), Valéry Gmyr(Inserm)
Cited by 0
Related Papers
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901